260 related articles for article (PubMed ID: 21124930)
1. IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.
Zimmerman M; Yang D; Hu X; Liu F; Singh N; Browning D; Ganapathy V; Chandler P; Choubey D; Abrams SI; Liu K
PLoS One; 2010 Nov; 5(11):e14076. PubMed ID: 21124930
[TBL] [Abstract][Full Text] [Related]
2. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
NoeDominguez-Romero A; Zamora-Alvarado R; Servín-Blanco R; Pérez-Hernández EG; Castrillon-Rivera LE; Munguia ME; Acero G; Govezensky T; Gevorkian G; Manoutcharian K
Hum Vaccin Immunother; 2014; 10(11):3201-13. PubMed ID: 25483665
[TBL] [Abstract][Full Text] [Related]
3. Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.
Ohmura Y; Yoshikawa K; Saga S; Ueda R; Kazaoka Y; Yamada S
Oncol Rep; 2008 May; 19(5):1265-70. PubMed ID: 18425386
[TBL] [Abstract][Full Text] [Related]
4. Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes.
Takahashi A; Torigoe T; Tamura Y; Kanaseki T; Tsukahara T; Sasaki Y; Kameshima H; Tsuruma T; Hirata K; Tokino T; Hirohashi Y; Sato N
Cell Stress Chaperones; 2012 Nov; 17(6):757-63. PubMed ID: 22777894
[TBL] [Abstract][Full Text] [Related]
5. Expression of IFNγR2 mutated in a dileucine internalization motif reinstates IFNγ signaling and apoptosis in human T lymphocytes.
Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F
Immunol Lett; 2010 Nov; 134(1):17-25. PubMed ID: 20709103
[TBL] [Abstract][Full Text] [Related]
6. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of T cells up-regulates expression of Ifi202, an interferon-inducible lupus susceptibility gene, through activation of JNK/c-Jun pathway.
Chen J; Panchanathan R; Choubey D
Immunol Lett; 2008 Jun; 118(1):13-20. PubMed ID: 18374989
[TBL] [Abstract][Full Text] [Related]
8. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.
Haeryfar SM; Conrad DM; Musgrave B; Hoskin DW
Immunol Cell Biol; 2005 Aug; 83(4):352-63. PubMed ID: 16033530
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1.
Wu X; Shao F; Yang Y; Gu L; Zheng W; Wu X; Gu Y; Shu Y; Sun Y; Xu Q
Int Immunopharmacol; 2014 Dec; 23(2):434-41. PubMed ID: 25261409
[TBL] [Abstract][Full Text] [Related]
10. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Blood; 2002 Nov; 100(9):3155-63. PubMed ID: 12384413
[TBL] [Abstract][Full Text] [Related]
11. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.
Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL
Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 down-regulates IFN-gamma R2 chain surface expression and desensitizes IFN-gamma/STAT-1 signaling in human T lymphocytes.
Bernabei P; Bosticardo M; Losana G; Regis G; Di Paola F; De Angelis S; Giovarelli M; Novelli F
Blood; 2003 Oct; 102(8):2933-9. PubMed ID: 12842994
[TBL] [Abstract][Full Text] [Related]
14. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ-STAT1-mediated NK2R expression is involved in the induction of antitumor effector CD8
Shen W; Wang X; Xiang H; Shichi S; Nakamoto H; Kimura S; Sugiyama K; Taketomi A; Kitamura H
Cancer Sci; 2023 May; 114(5):1816-1829. PubMed ID: 36715504
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
Zanovello P; Vallerani E; Biasi G; Landolfo S; Collavo D
J Immunol; 1988 Feb; 140(4):1341-4. PubMed ID: 2830339
[TBL] [Abstract][Full Text] [Related]
17. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
Dotti G; Savoldo B; Pule M; Straathof KC; Biagi E; Yvon E; Vigouroux S; Brenner MK; Rooney CM
Blood; 2005 Jun; 105(12):4677-84. PubMed ID: 15713795
[TBL] [Abstract][Full Text] [Related]
18. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Sun L; Guo H; Jiang R; Lu L; Liu T; He X
Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
[TBL] [Abstract][Full Text] [Related]
19. Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack.
Bergmann-Leitner ES; Abrams SI
Cancer Immunol Immunother; 2000 Jul; 49(4-5):193-207. PubMed ID: 10941902
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
